Sarcoma  >>  Puyouheng (pucotenlimab)  >>  Phase 2
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Puyouheng (pucotenlimab) / Taizhou Hanzhong Biopharma, Lepu Med
NCT06456892: Effectiveness of Pucotenlimab Combined With Standard Chemotherapy Regimen

Recruiting
1/2
82
RoW
Pucotenlimab
Sun Yat-sen University
Rhabdomyosarcoma, Pediatric Cancer
06/26
12/26

Download Options